Pharmacokinetics of meropenem during advanced organ support (ADVOS®) and continuous renal replacement therapy

Int J Artif Organs. 2021 Oct;44(10):783-786. doi: 10.1177/03913988211021101. Epub 2021 Jun 18.

Abstract

The advanced organ support (ADVOS) system allows to eliminate water-soluble as well as protein-bound molecules. Despite its clinical features, to date nothing is known about the elimination of clinically relevant drugs such as antiinfectives. Therefore, we report a case treated with ADVOS, continuous renal replacement therapy (CRRT), and meropenem (1 g 8-hourly) for empiric sepsis therapy monitored by meropenem drug levels. ADVOS showed more efficient elimination of meropenem compared to CRRT which has to be considered when evaluating dosing regimens.

Keywords: Pharmacokinetic; antibiotics; apheresis and detoxification techniques; artificial kidney; liver failure; solute kinetics in dialysis.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Continuous Renal Replacement Therapy*
  • Critical Illness
  • Humans
  • Meropenem
  • Renal Replacement Therapy

Substances

  • Anti-Bacterial Agents
  • Meropenem